StockDuty ← Dashboard Sep 15, 2026 04:31 PM ET
CatalystCorporate

TRANSMEDICS APPOINTS FERNANDO ARAUJO CFO AND REITERATES $737 MILLION TO $757 MILLION 2026 REVENUE OUTLOOK - PULSE 2.0 - GNEWS

CFO appointment plus reiterated $737–$757 million 2026 revenue outlook signals corporate catalysts.

What changed
CFO appointment plus reiterated $737–$757 million 2026 revenue outlook signals corporate catalysts.
Why it matters
CFO appointment plus reiterated $737–$757 million 2026 revenue outlook signals corporate catalysts. — impact context not separately stored; see What changed.
Sources
gnews
Related signals
FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →$FMX →